# CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

> **NCT06101381** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Sao Paulo** · enrollment: 81 (estimated)

## Conditions studied

- Leukemia, Acute Lymphoblastic
- Lymphoma, Non-Hodgkin

## Interventions

- **BIOLOGICAL:** CART-19

## Key facts

- **NCT ID:** NCT06101381
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-21
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06101381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06101381, "CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06101381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*